awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q22241134-BE726495-68B4-42C0-8899-7C116FD33ECE
Q22241134-BE726495-68B4-42C0-8899-7C116FD33ECE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q22241134-BE726495-68B4-42C0-8899-7C116FD33ECE
Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations
P2860
Q22241134-BE726495-68B4-42C0-8899-7C116FD33ECE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q22241134-BE726495-68B4-42C0-8899-7C116FD33ECE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ed886593a7a3f1450063533ffe1689c12c8c222a
P2860
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.